{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T10:46:14Z","timestamp":1782470774947,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.eprac.2026.03.090","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:04:22Z","timestamp":1775181862000},"page":"1078-1085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Determinants of Health-Related Quality of Life in Differentiated and Poorly Differentiated Thyroid Cancer Patients With Structural Incomplete Response: A Multicenter Cross-Sectional Study"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7310-5706","authenticated-orcid":false,"given":"Marco","family":"Miniotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Nervo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Minaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Elisei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"De Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialuisa","family":"Appetecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Pellegriti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Leombruni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Arvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.eprac.2026.03.090_bib1","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1158\/1055-9965.EPI-21-1440","article-title":"Epidemiology of thyroid cancer","volume":"31","author":"Kitahara","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1016\/j.eprac.2026.03.090_bib2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00268-018-4479-z","article-title":"Overall survival of Papillary thyroid carcinoma patients: a single-institution long-term Follow-Up of 5897 patients","volume":"42","author":"Ito","year":"2018","journal-title":"World J Surg"},{"issue":"8","key":"10.1016\/j.eprac.2026.03.090_bib3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association Management Guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.eprac.2026.03.090_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000502229","article-title":"2019 European Thyroid Association Guidelines for the treatment and Follow-Up of advanced radioiodine-refractory thyroid cancer","volume":"8","author":"Fugazzola","year":"2019","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.eprac.2026.03.090_bib5","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.2147\/CMAR.S340967","article-title":"Management of progressive radioiodine-refractory thyroid carcinoma: current perspective","volume":"14","author":"Nervo","year":"2022","journal-title":"Cancer Manag Res"},{"issue":"12","key":"10.1016\/j.eprac.2026.03.090_bib6","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.eprac.2026.03.090_bib7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/03008916211025098","article-title":"Systematic review of health-related quality of life following thyroid cancer","volume":"108","author":"Walshaw","year":"2022","journal-title":"Tumor"},{"issue":"4","key":"10.1016\/j.eprac.2026.03.090_bib8","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.amjsurg.2022.05.023","article-title":"Discovering domains important to health-related quality of life in differentiated thyroid cancer","volume":"224","author":"Hsiao","year":"2022","journal-title":"Am J Surg"},{"key":"10.1016\/j.eprac.2026.03.090_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.999331","article-title":"Health-related quality of life in long-term differentiated thyroid cancer survivors: a cross-sectional Tunisian-based study","volume":"13","author":"Missaoui","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"10.1016\/j.eprac.2026.03.090_bib10","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1089\/thy.2016.0632","article-title":"Papillary thyroid cancer: the good and bad of the \"Good Cancer\"","volume":"27","author":"Randle","year":"2017","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.eprac.2026.03.090_bib11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s12020-021-02786-y","article-title":"Distress, anxiety, depression and unmet needs in thyroid cancer survivors: a longitudinal study","volume":"74","author":"Dionisi-Vici","year":"2021","journal-title":"Endocrine"},{"issue":"8","key":"10.1016\/j.eprac.2026.03.090_bib12","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00259-015-3022-9","article-title":"Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme","volume":"42","author":"Gamper","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.eprac.2026.03.090_bib13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00268-015-3300-5","article-title":"Quality of life in thyroid cancer is similar to that of other cancers with worse survival","volume":"40","author":"Applewhite","year":"2016","journal-title":"World J Surg"},{"issue":"9","key":"10.1016\/j.eprac.2026.03.090_bib14","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1089\/thy.2019.0652","article-title":"Patient report of recurrent and persistent thyroid cancer","volume":"30","author":"Papaleontiou","year":"2020","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.eprac.2026.03.090_bib15","first-page":"65","article-title":"Quality of life during treatment with Lenvatinib for thyroid cancer: the patients' perspective beyond the medical evaluation","volume":"10","author":"Nervo","year":"2021","journal-title":"Eur Thyroid J"},{"issue":"3","key":"10.1016\/j.eprac.2026.03.090_bib16","first-page":"1643","article-title":"Lenvatinib in advanced radioiodine-refractory thyroid cancer: a snapshot of real-life clinical practice","volume":"38","author":"Nervo","year":"2018","journal-title":"Anticancer Res"},{"issue":"7","key":"10.1016\/j.eprac.2026.03.090_bib17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJMoa1406470","article-title":"Lenvatinib versus Placebo in radioiodine-refractory thyroid cancer","volume":"372","author":"Schlumberger","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.eprac.2026.03.090_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1089\/thy.2017.0205","article-title":"Lenvatinib for the treatment of radioiodine-refractory thyroid cancer in real-life practice","volume":"28","author":"Berdelou","year":"2018","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.eprac.2026.03.090_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12020-017-1233-5","article-title":"Incidence and timing of common adverse events in Lenvatinib-treated patients from the SELECT trial and their association with survival outcomes","volume":"56","author":"Haddad","year":"2017","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.eprac.2026.03.090_bib20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1089\/thy.2020.0276","article-title":"Safety and quality-of-life data from an Italian expanded access program of Lenvatinib for treatment of thyroid cancer","volume":"31","author":"Giani","year":"2021","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.eprac.2026.03.090_bib21","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1002\/cam4.5308","article-title":"Health-related quality-of-life analyses from a multicenter, randomized, double-blind phase 2 study of patients with differentiated thyroid cancer treated with Lenvatinib 18 or 24 mg\/day","volume":"12","author":"Taylor","year":"2023","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.eprac.2026.03.090_bib22","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eprac.2026.03.090_bib23","series-title":"EORTC QLQ-C30 scoring manual","author":"Fayers","year":"2001"},{"issue":"4","key":"10.1016\/j.eprac.2026.03.090_bib24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/ERC-16-0530","article-title":"The EORTC module for quality of life in patients with thyroid cancer: phase III","volume":"24","author":"Singer","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"10.1016\/j.eprac.2026.03.090_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"issue":"9","key":"10.1016\/j.eprac.2026.03.090_bib26","first-page":"1078","article-title":"International phase IV field Study for the reliability and validity of the European Organisation for Research and treatment of cancer thyroid cancer module EORTC QLQ-THY34","volume":"33","author":"Singer","year":"2023","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.eprac.2026.03.090_bib27","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1089\/thy.2015.0589","article-title":"Thyroid cancer-specific quality of life and health-related quality of life in young adult thyroid cancer survivors","volume":"26","author":"Goldfarb","year":"2016","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.eprac.2026.03.090_bib28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s42000-020-00186-x","article-title":"Quality of life of patients more than 1 year after surgery for thyroid cancer","volume":"19","author":"B\u00fcttner","year":"2020","journal-title":"Hormones (Athens)"},{"issue":"1","key":"10.1016\/j.eprac.2026.03.090_bib29","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1186\/s12889-022-13211-y","article-title":"EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals","volume":"22","author":"Pilz","year":"2022","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.eprac.2026.03.090_bib30","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00405-024-08471-w","article-title":"Assessment of quality of life in thyroid cancer patients using the EORTC thyroid-specific questionnaire: a prospective cross-sectional study","volume":"281","author":"Thiagarajan","year":"2024","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.eprac.2026.03.090_bib31","doi-asserted-by":"crossref","DOI":"10.1177\/10732748211029726","article-title":"Health-Related quality of life in Asian differentiated thyroid cancer survivors","volume":"28","author":"Chan","year":"2021","journal-title":"Cancer Control"},{"issue":"5","key":"10.1016\/j.eprac.2026.03.090_bib32","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.surg.2018.06.042","article-title":"Benchmarking health-related quality of life in thyroid cancer versus other cancers and United States normative data","volume":"164","author":"Goswami","year":"2018","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.eprac.2026.03.090_bib33","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1210\/jc.2018-01383","article-title":"Time to separate persistent from recurrent differentiated thyroid cancer: different conditions with different outcomes","volume":"104","author":"Sapuppo","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.eprac.2026.03.090_bib34","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1210\/clinem\/dgae181","article-title":"Survival predictors of radioiodine-refractory differentiated thyroid cancer treated with Lenvatinib in real life","volume":"109","author":"Marotta","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2026.03.090_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12020-025-04228-5","article-title":"Predictors of response to Lenvatinib in advanced differentiated thyroid cancer: focus on the CONUT score","volume":"89","author":"Talpacci","year":"2025","journal-title":"Endocrine"},{"issue":"23","key":"10.1016\/j.eprac.2026.03.090_bib36","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1200\/JCO.2015.65.7742","article-title":"Quality of life in patients with advanced cancer: Differential Association with performance status and systemic inflammatory response","volume":"34","author":"Laird","year":"2016","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.eprac.2026.03.090_bib37","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s11136-013-0559-6","article-title":"Gender-specific quality of life after cancer in young adulthood: a comparison with the general population","volume":"23","author":"Geue","year":"2014","journal-title":"Qual Life Res"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26009146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26009146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:48:42Z","timestamp":1782467322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26009146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1530891X26009146"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.03.090","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determinants of Health-Related Quality of Life in Differentiated and Poorly Differentiated Thyroid Cancer Patients With Structural Incomplete Response: A Multicenter Cross-Sectional Study","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.03.090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}